LANTERN PHARMA
LTRN Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2024-07-15
2024-07-17
BHATIA KISHOR
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
35,000
$0.00
1
$34.3M
2024-07-15
2024-07-17
MACCECCHINI MARIA-LUISA
A - Grant
Stock Option (Right to Buy)
5,000
$0.00
1
$34.3M
2024-07-15
2024-07-17
MARGRAVE DAVID
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
52,000
$0.00
1
$34.3M
2024-07-15
2024-07-17
SHARMA PANNA
President and CEO
A - Grant
Stock Option (Right to Buy)
70,000
$0.00
1
$34.3M
2022-10-20
2022-10-24
MACCECCHINI MARIA-LUISA
A - Grant
Stock Option (Right to Buy)
3,200
$0.00
1
$34.3M
2022-08-06
2022-08-09
SHARMA PANNA
President and CEO
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$34.3M
2021-10-29
2021-11-02
MARGRAVE DAVID
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
26,100
$0.00
1
$34.3M
2021-10-29
2021-11-02
BHATIA KISHOR
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
17,400
$0.00
1
$34.3M
2020-06-16
2020-06-17
GREEN PARK GOLF VENTURES II, LLC
C - Conversion
Series A Preferred Stock, par value $0.01
-75,688
1
$34.3M
2020-06-15
2020-06-17
GREEN PARK GOLF VENTURES II, LLC
C - Conversion
Common Stock, par value $0.0001
466K
3
$34.3M
2020-06-15
2020-06-17
GREEN PARK GOLF VENTURES II, LLC
C - Conversion
Series A Preferred Stock, par value $0.01
-192K
2
$34.3M